Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-020807
Filing Date
2025-07-31
Accepted
2025-07-31 21:05:18
Documents
2
Period of Report
2025-07-29

Document Format Files

Seq Description Document Type Size
1 form4-07312025_090714.html 4  
1 form4-07312025_090714.xml 4 6124
2 ex24-07312025_090715.htm EX-24 4526
  Complete submission text file 0001415889-25-020807.txt   12265
Mailing Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 650-231-6625
ALUMIS INC. (Issuer) CIK: 0001847367 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ALUMIS INC. 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Richardson Derrick (Reporting) CIK: 0002022896 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42143 | Film No.: 251173399